搜尋結果
2024年5月23日 · There was an association between changes in subcutaneous fat quality on CT and prognosis, particularly among female patients with advanced NSCLC treated with immune checkpoint inhibitors, either as monotherapy or combined with chemotherapy.
2024年5月19日 · Key Points Question Does the connective tissue growth factor inhibitor pamrevlumab decrease the rate of decline in lung function for patients with idiopathic pulmonary fibrosis compared with placebo? Findings In this phase 3 randomized clinical trial including 356 adults with idiopathic pulmonary fibrosis, the decline in forced vital capacity at 48 weeks did not differ significantly between ...
2024年5月13日 · Ophthalmology Neurology. This narrative review describes the phenotypes of anti-GQ1b antibody syndrome to aid in its diagnosis in light of its various clinical presentations,
2024年6月1日 · Fecal immunochemical tests (FITs) for hemoglobin are the most widely used screening tests for colorectal cancer (CRC) globally. 1 However, they have limited sensitivity in detecting early-stage CRC and CRC precursors. 2 In 2023, the CRC-PREVENT study, a blinded, prospective, cross-sectional study that enrolled the target population for CRC screening, demonstrated increased sensitivity for CRC ...
2024年5月21日 · Importance While β-blockers are associated with decreased mortality in cardiovascular disease (CVD), exacerbation-prone patients with chronic obstructive pulmonary disease (COPD) who received metoprolol in the Beta-Blockers for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease (BLOCK-COPD) trial experienced increased risk of exacerbations requiring hospitalization.
2024年5月22日 · The Pediatric Pulmonology Practice at Valley Children s offers the opportunity to join a team of seven pediatric pulmonologists providing expert diagnosis and management of complex respiratory conditions and disorders in infants, children and young adults.
2024年5月23日 · Importance The human papillomavirus (HPV) vaccine is safe and effective, yet vaccination coverage remains below public health objectives in many countries. Objective To examine the effectiveness of a 3-component intervention on HPV vaccination coverage among adolescents aged 11 to 14 years 2 months after the intervention ended, each component being applied alone or in combination.
